PLACENTA ACCRETA SPECTRUM DISORDER IN THE FIRST SEMESTER: A SYSTEMATIC REVIEW
Keywords:
First semester, Misscariage, Placenta accreta, PregnancyAbstract
Placenta accreta is one of the deadliest obstetric placental implantation anomalies that can result in severe bleeding, shock, uterine perforation, secondary infection, and even death. It is considered to be one of the most serious placental anomalies. It was demonstrated that higher blood levels of PIGF remained to be strongly and positively related with placenta accreta. Furthermore, a history of a previous cesarean section, as well as smoking, were found to be substantially associated with placenta accreta in a positive way. PIGF has been identified as a marker for placental trophoblasts in studies. Furthermore, having a low PIGF level was connected with an increased risk of developing preeclampsia, pregnancy loss, early delivery, and low birth weight. These pregnancy problems and placenta accreta are all symptoms of underlying diseases that impair placental development. The placenta accreta begins to form during the first trimester of pregnancy. PAPP-A levels in the blood were found to be significantly and favorably associated with placenta accreta. Previous study as well as the current investigation have demonstrated that the levels of placental markers in maternal serum may fluctuate in pregnant women who either have or are destined to acquire placental accreta. Markers identified in maternal serum during the first trimester may aid in the prenatal diagnosis of placenta accreta. Furthermore, being aware of the potential risks at an early stage may assist to better explain the findings of an MRI or ultrasonography.
References
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. Januari 2018;218(1):75–87.
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. Mei 2005;192(5):1458–61.
Landon M, Galan H, Jauniaux E, Driscoll D, Berghella V, Grobman W, et al. Gabbe’s Obstetrics: Normal and Problem Pregnancies. 8 ed. Otawwa: Saunders Inc;
Tamara L. Callahan ABC. Blueprint Obstetrics &Gynecology. sixth edit. Philadelphia: Lippincott Williams&Wilkins; 2013.
Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers. Dis Markers. 2018;2018:1507674.
Kenneth JL, Steven LB, Catherine YS, Jodi SD, Barbara LH, Cunningham K. Williams Obstetri. 26 ed. New York: The McGraw-Hill Companies; 2020.
Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and Preeclampsia: Common Pathophysiological Mechanisms [Internet] Vol. 9, Frontiers in Physiology . 2018. Tersedia pada: https://www.frontiersin.org/article/10.3389/fphys.2018.01838
Wang F, Zhang L, Zhang F, Wang J, Wang Y, Man D. First trimester serum PIGF is associated with placenta accreta. Placenta. November 2020;101:39–44.
Wang F, Chen S, Wang J, Wang Y, Ruan F, Shu H, et al. First trimester serum PAPP-A is associated with placenta accreta: a retrospective study. Arch Gynecol Obstet. Maret 2021;303(3):645–52.
Happe SK, Rac MWF, Moschos E, Wells CE, Dashe JS, McIntire DD, et al. Prospective First-Trimester Ultrasound Imaging of Low Implantation and Placenta Accreta Spectrum. J ultrasound Med Off J Am Inst Ultrasound Med. Oktober 2020;39(10):1907–15.
Abinader RR, Macdisi N, El Moudden I, Abuhamad A. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. April 2022;59(4):457–64.
Wang Y-L, Weng S-S, Huang W-C. First-trimester abortion complicated with placenta accreta: A systematic review. Taiwan J Obstet Gynecol [Internet] 2019;58(1):10–4. Tersedia pada:
https://www.sciencedirect.com/science/article/pii/S1028455918303097
Lim S, Ha S-Y, Lee K-B, Lee J-S. Retained placenta accreta after a first-trimester abortion manifesting as an uterine mass. Obstet Gynecol Sci. 2013;56(3):205–7.
Su H-W, Yi Y-C, Tseng J-J, Chen W-C, Chen Y-F, Kung H-F, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353–7.
Dreux S, Salomon LJ, Muller F, Goffinet F, Oury J-F, Group ABAS, et al. Second-trimester maternal serum markers and placenta accreta. Prenat Diagn [Internet] 1 Oktober 2012;32(10):1010–2. Tersedia pada:
https://doi.org/10.1002/pd.3932
Pang V, Bates DO, Leach L. Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin. Clin Sci.
;131(23):2763–75.
Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226–32.
Kingdom JC, Hobson SR, Murji A, Allen L, Windrim RC, Lockhart E, et al. Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020. Am J Obstet Gynecol. 2020;223(3):322–9.
Ballas J, Pretorius D, Hull AD, Resnik R, Ramos GA. Identifying sonographic markers for placenta accreta in the first trimester. J Ultrasound Med. 2012;31(11):1835–41.
Yu FNY, Leung KY. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders. Best Pract Res Clin Obstet Gynaecol. April 2021;72:13–24.
Cheung CS-Y, Chan BC-P. The sonographic appearance and obstetric management of placenta accreta. Int J Womens Health. 2012;4:587–94.
Comstock CH, Lee W, Vettraino IM, Bronsteen RA. The early sonographic appearance of placenta accreta. J ultrasound Med. 2003;22(1):19–23.
Wang Y-L, Su T-H, Huang W-C, Weng S-S. Laparoscopic management of placenta increta after late first-trimester dilation and evacuation manifesting as an unusual uterine mass. J Minim Invasive Gynecol. 2011;18(2):250–3.
Committee opinion no. 529: placenta accreta. Obstet Gynecol. Juli 2012;120(1):207–11.
Garmi G, Salim R. Epidemiology, Etiology, Diagnosis, and Management of Placenta Accreta. Wong HS, editor. Obstet Gynecol Int [Internet] 2012;2012:873929. Tersedia pada: https://doi.org/10.1155/2012/873929
Takeda A, Koyama K, Imoto S, Mori M, Nakano T, Nakamura H. Conservative management of placenta increta after first trimester abortion by transcatheter arterial chemoembolization: a case report and review of the literature. Arch Gynecol Obstet. 2010;281(3):381–6.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
